Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with Chemoradiotherapy in Locally Advanced NSCLC
NCT01158144Phase 2Unknown
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Zhejiang Cancer Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01158144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158144.